NovaBridge Biosciences to present expanded Givastomig safety and efficacy data in 2026
NovaBridge Biosciences said expanded safety and efficacy data for Givastomig will be presented at the European Society for Medical Oncology 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.